(Q35046024)

6 August 2017

1 reference

title

Heart failure and the brain: new perspectives (English)

1 reference

6 August 2017

0 references

Robert B Felder

1

1 reference

6 August 2017

Joseph Francis

2

1 reference

6 August 2017

Zhi-Hua Zhang

3

1 reference

6 August 2017

Shun-Guang Wei

4

1 reference

6 August 2017

Robert M Weiss

5

1 reference

6 August 2017

Alan Kim Johnson

6

1 reference

6 August 2017

1 February 2003

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

6 August 2017

1 reference

6 August 2017

284

1 reference

6 August 2017

2

1 reference

6 August 2017

R259-76

1 reference

Guiding principles for research involving animals and human beings.

6 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Tumor necrosis factor and interleukin-1 may regulate renin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Regulation of prostacyclin synthesis by angiotensin II and TNF-alpha in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Baroreceptor denervation profoundly enhances cardiovascular responses to central angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Cytokines as emerging targets in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Plasma corticosterone and volume after preoptic recess lesions and volume depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Localized injections of 6-hydroxydopamine into lamina terminalis-associated structures: effects on experimentally induced drinking and pressor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Selective catecholamine depletion of structures along the ventral lamina terminalis: effects on experimentally-induced drinking and pressor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investiga

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Ventrolateral medullary neurons relay cardiovascular inputs to the paraventricular nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Functional organization of central pathways regulating the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Free radicals, cytokines and nitric oxide in cardiac failure and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Activation by systemic angiotensin II of neurochemically identified neurons in rat hypothalamic paraventricular nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Cardiac aldosterone production and ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Reflex regulation of renal nerve activity in cardiac failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Vascular and renal prostaglandins as counter-regulatory systems in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Heart failure: a growing public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Clinical pharmacology of thalidomide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Adrenergic nervous system in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Angiotensin II: a peptidergic neurotransmitter in central autonomic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Tumor necrosis factor in CHF: a double facet cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Protective effects of carvedilol in the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Forebrain-mediated adaptations to myocardial infarction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Development of a hybrid cardiovascular graft using a tissue engineering approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Central mineralocorticoid receptor blockade improves volume regulation and reduces sympathetic drive in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Progression of heart failure after myocardial infarction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Histochemical and morphological characteristics of canine cardiac mast cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The inflammatory response in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Central hypertensive effects of aldosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Reactive oxygen species as mediators of angiotensin II signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The corticotropin-releasing factor release in rat hypophysial portal blood is mediated by brain catecholamines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Hypothalamic projections to cardiovascular centers of the medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The area postrema plays no role in the pressor action of angiotensin in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Norepinephrine-induced CRH and AVP gene transcription within the hypothalamus: differential regulation by corticosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The autonomic nervous system as a communication channel between the brain and the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Blockade of brain 'ouabain' prevents the impairment of baroreflexes in rats after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The extended amygdala and salt appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The neuroendocrinology of thirst and salt appetite: visceral sensory signals and mechanisms of central integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

gamma-Aminobutyric acid antagonist blocks baroreceptor-activated inhibition of neurosecretory cells in the hypothalamic paraventricular nucleus of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Effects of baroreceptor activation on single unit activity of the anteroventral third ventricle region of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Mechanisms of the central pressor action of angiotensin II in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Descending pathways to sympathetic and parasympathetic preganglionic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Clinical Trials Update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Peripheral endotoxin increases splenic sympathetic nerve activity via central prostaglandin synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The role of the vagus nerve in cytokine-to-brain communication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Role for the subfornical organ in vasopressin release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Physiological actions of angiotensin II mediated by AT1 AND AT2 receptors in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Anteroventral wall of the third ventricle and dorsal lamina terminalis: headquarters for control of body fluid homeostasis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Do ACE inhibitors or angiotensin II antagonists reduce total mortality and arrhythmic mortality? A critical review of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The effects of interleukin-1β on the activity of adrenal, splenic and renal sympathetic nerves in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Efferent neural projections of angiotensin receptor (AT1) expressing neurones in the hypothalamic paraventricular nucleus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Tumor necrosis factor-alpha: a neuromodulator in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Neuroendocrine changes in heart failure and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Role of paraventricular nucleus in mediating sympathetic outflow in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Neurohumoral activation in heart failure: role of paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Electrical stimulation of paraventricular nucleus increases plasma renin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

A comparison of the hemodynamic effects produced by electrical stimulation of subnuclei of the paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Alternative pathways of neural control of the immune process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Role of vasopressin in experimental heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Annual review prize lecture cytokines - killers in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Angiotensin-converting enzyme is present in the subfornical organ and other circumventricular organs of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Effect of cervical vagotomy on sympathetic nerve responses to peripheral interleukin-1beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Inhibition of tissue angiotensin converting enzyme. Quantitation by autoradiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The brain is a possible target for an angiotensin-converting enzyme inhibitor in the treatment of chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Central noradrenergic pathways for the integration of hypothalamic neuroendocrine and autonomic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Cerebral uptake of a 3 H-labelled spirolactone compound in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Aldosterone as a mediator in cardiovascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Caudal ventrolateral medulla can alter vasopressin and arterial pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Hypothalamic Integration: Organization of the Paraventricular and Supraoptic Nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Sympathetic inhibition and attenuation of spontaneous hypertension by PVN lesions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Aldosterone reduces baroreceptor discharge in the dog

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Aldosterone in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Na depletion-induced Na appetite of sheep is independent of brain angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Effects of increased circulating angiotensin II (AII) on fluid exchange and binding of All in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Continuous blockade of brain mineralocorticoid receptors impairs spatial learning in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

From the HOPE to the ONTARGET and the TRANSCEND studies: challenges in improving prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Blunted nitric oxide-mediated inhibition of renal nerve discharge within PVN of rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Nitric oxide within the paraventricular nucleus mediates changes in renal sympathetic nerve activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Altered number of diaphorase (NOS) positive neurons in the hypothalamus of rats with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

The renin-angiotensin-aldosterone system excites hypothalamic paraventricular nucleus neurons in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Neural regulation of sympathetic nerve activity in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

Eplerenone: A Selective Aldosterone Receptor Antagonist (SARA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

THE ROLE OF CYTOKINES IN THE FAILING HUMAN HEART

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00317.2002

10.1152/AJPREGU.00317.2002

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference